Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

77.07 

-0.58 -0.8%

as of Oct 23 '18

52 Week Range:

59.07 80.68


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics. It also provides specialty pharmacy services and mail services; and manages in-store clinics. As of August 31, 2018, this segment operated 9,560 retail stores under the Walgreens and Duane Reade brands in the United States; and 7 specialty pharmacies, as well as approximately 400 in-store clinic locations. The Retail Pharmacy International segment sells prescription drugs; and health, beauty, personal care, and other consumer products through its pharmacy-led health and beauty stores and optical practices, as well as through boots.com and an integrated mobile application. This segment operated 4,767 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 618 optical practices, including 167 on a franchise basis. The Pharmaceutical Wholesale segment engages in the wholesale and distribution of specialty and generic pharmaceuticals, health and beauty products, and home healthcare supplies and equipment, as well as provides related services to pharmacies and other healthcare providers. This segment operates in the United Kingdom, Germany, France, Turkey, Spain, the Netherlands, Egypt, Norway, Romania, the Czech Republic, and Lithuania. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Aug '08 Aug '09 Aug '10 Aug '11 Aug '12 Aug '13 Aug '14 Aug '15 Aug '16 Aug '17 Aug '18
Equity (BVPS) 12.67
14.54
15.34
16.70
19.32
20.05
22.54
28.96
28.51
29.89
29.13
growth rate 14.8% 5.5% 8.9% 15.7% 3.8% 12.4% 28.5% -1.6% 4.8% -2.5%
Earnings BIT 3,878.00
5,190.00
6,449.00
6,246.00
6,363.00
growth rate 33.8% 24.3% -3.2% 1.9%
Avg.PE 35.37
21.17
28.19
16.28
17.02
growth rate -40.2% 33.2% -42.3% 4.6%
ROA 10.34
8.44
8.13
10.10
6.98
7.11
5.32
7.97
5.90
5.88
7.49
growth rate -18.4% -3.7% 24.2% -30.9% 1.9% -25.2% 49.8% -26.0% -0.3% 27.4%
ROE 17.99
14.73
14.53
18.56
12.86
13.00
9.68
16.45
13.74
14.22
18.79
growth rate -18.1% -1.4% 27.7% -30.7% 1.1% -25.5% 69.9% -16.5% 3.5% 32.1%
ROIC 15.62
13.27
12.79
16.20
10.41
10.18
7.81
12.02
8.86
9.13
12.43
growth rate -15.0% -3.6% 26.7% -35.7% -2.2% -23.3% 53.9% -26.3% 3.1% 36.1%
Cur. Ratio 1.57
1.78
1.60
1.52
1.23
1.34
1.38
1.19
1.52
1.06
0.82
growth rate 13.4% -10.1% -5.0% -19.1% 8.9% 3.0% -13.8% 27.7% -30.3% -22.6%
Quick Ratio 0.45
0.75
0.58
0.50
0.40
0.53
0.66
0.59
0.94
0.53
0.34
growth rate 66.7% -22.7% -13.8% -20.0% 32.5% 24.5% -10.6% 59.3% -43.6% -35.9%
Leverage 1.74
1.75
1.82
1.85
1.83
1.82
1.82
2.23
2.43
2.40
2.62
growth rate 0.6% 4.0% 1.7% -1.1% -0.6% 0.0% 22.5% 9.0% -1.2% 9.2%
Balance Sheet Aug '08 Aug '09 Aug '10 Aug '11 Aug '12 Aug '13 Aug '14 Aug '15 Aug '16 Aug '17 Aug '18
Acct.Receivable 2,167.00
2,632.00
3,218.00
6,849.00
6,260.00
6,528.00
6,573.00
growth rate 21.5% 22.3% 112.8% -8.6% 4.3% 0.7%
Acct.Payable 7,403.00
8,313.00
4,315.00
10,088.00
11,000.00
12,494.00
13,566.00
growth rate 12.3% -48.1% 133.8% 9.0% 13.6% 8.6%
Cur.Assets 10,760.00
11,874.00
12,242.00
19,657.00
25,883.00
19,753.00
17,846.00
growth rate 10.4% 3.1% 60.6% 31.7% -23.7% -9.7%
Total Assets 33,462.00
35,481.00
37,250.00
68,782.00
72,688.00
66,009.00
68,124.00
growth rate 6.0% 5.0% 84.7% 5.7% -9.2% 3.2%
Cash 1,297.00
2,106.00
2,646.00
3,000.00
9,807.00
3,301.00
785.00
growth rate 62.4% 25.6% 13.4% 226.9% -66.3% -76.2%
Inventory 7,036.00
6,852.00
6,076.00
8,678.00
8,956.00
8,899.00
9,565.00
growth rate -2.6% -11.3% 42.8% 3.2% -0.6% 7.5%
Cur.Liabilities 8,722.00
8,883.00
8,895.00
16,557.00
17,013.00
18,547.00
21,667.00
growth rate 1.9% 0.1% 86.1% 2.8% 9.0% 16.8%
Liabilities 15,226.00
16,027.00
16,633.00
37,482.00
42,407.00
37,735.00
41,435.00
growth rate 5.3% 3.8% 125.4% 13.1% -11.0% 9.8%
LT Debt 4,073.00
4,477.00
3,760.00
13,315.00
18,705.00
12,684.00
12,431.00
growth rate 9.9% -16.0% 254.1% 40.5% -32.2% -2.0%
Equity 18,236.00
19,454.00
20,513.00
30,861.00
29,880.00
27,466.00
26,007.00
growth rate 6.7% 5.4% 50.5% -3.2% -8.1% -5.3%
Common Shares 996.00
991.00
987.00
925.00
880.00
955.00
965.00
1,054.00
1,091.00
1,079.00
995.00
growth rate -0.5% -0.4% -6.3% -4.9% 8.5% 1.1% 9.2% 3.5% -1.1% -7.8%
Cash Flow Statement Aug '08 Aug '09 Aug '10 Aug '11 Aug '12 Aug '13 Aug '14 Aug '15 Aug '16 Aug '17 Aug '18
Capital Expenditures 1,550.00
1,212.00
1,106.00
1,251.00
1,325.00
1,351.00
1,367.00
growth rate -21.8% -8.8% 13.1% 5.9% 2.0% 1.2%
Cash Dividends 787.00
1,040.00
1,199.00
1,384.00
1,563.00
1,625.00
1,739.00
growth rate 32.2% 15.3% 15.4% 12.9% 4.0% 7.0%
Cash From OA 4,431.00
4,301.00
3,893.00
5,664.00
7,847.00
7,251.00
8,265.00
growth rate -2.9% -9.5% 45.5% 38.5% -7.6% 14.0%
FCF per Share 0.58
2.20
2.76
2.63
3.27
2.79
2.57
4.28
4.96
6.04
5.89
growth rate 279.3% 25.5% -4.7% 24.3% -14.7% -7.9% 66.5% 15.9% 21.8% -2.5%
Sale Purchase of Stock -1,026.00
-129.00
612.00
503.00
235.00
217.00
growth rate 0.0% 100.0% -17.8% -53.3% -7.7%
FCF 814.00
2,184.00
2,730.00
2,430.00
2,881.00
3,089.00
2,787.00
4,413.00
6,522.00
5,900.00
6,898.00
growth rate 168.3% 25.0% -11.0% 18.6% 7.2% -9.8% 58.3% 47.8% -9.5% 16.9%
Income Statement Aug '08 Aug '09 Aug '10 Aug '11 Aug '12 Aug '13 Aug '14 Aug '15 Aug '16 Aug '17 Aug '18
Sales 71,633.00
72,217.00
76,392.00
103,444.00
117,351.00
118,214.00
131,537.00
growth rate 0.8% 5.8% 35.4% 13.4% 0.7% 11.3%
Op.Income 2,127.00
2,548.00
3,878.00
5,190.00
6,449.00
6,246.00
6,363.00
growth rate 19.8% 52.2% 33.8% 24.3% -3.2% 1.9%
IBT 3,376.00
4,047.00
3,557.00
5,335.00
5,188.00
4,861.00
6,029.00
growth rate 19.9% -12.1% 50.0% -2.8% -6.3% 24.0%
Net Income 2,127.00
2,548.00
1,932.00
4,220.00
4,173.00
4,078.00
5,024.00
growth rate 19.8% -24.2% 118.4% -1.1% -2.3% 23.2%
EPS 2.17
2.02
2.12
2.94
2.42
2.67
2.00
4.00
3.82
3.78
5.05
growth rate -6.9% 5.0% 38.7% -17.7% 10.3% -25.1% 100.0% -4.5% -1.1% 33.6%
Gross Profit 20,342.00
21,119.00
21,569.00
26,859.00
29,874.00
29,162.00
30,792.00
growth rate 3.8% 2.1% 24.5% 11.2% -2.4% 5.6%

Quarterly Statements

Item Name Aug '17 Nov '17 Feb '18 May '18 Aug '18
Earnings BIT 1,991.00
1,453.00
1,942.00
1,465.00
1,503.00
growth rate -27.0% 33.7% -24.6% 2.6%
Balance Sheet Aug '17 Nov '17 Feb '18 May '18 Aug '18
Acct.Receivable 6,528.00
6,858.00
7,281.00
7,159.00
6,573.00
growth rate 5.1% 6.2% -1.7% -8.2%
Acct.Payable 12,494.00
13,570.00
13,301.00
13,089.00
13,566.00
growth rate 8.6% -2.0% -1.6% 3.6%
Cur.Assets 19,753.00
19,681.00
20,358.00
19,988.00
17,846.00
growth rate -0.4% 3.4% -1.8% -10.7%
Total Assets 66,009.00
66,618.00
70,816.00
70,152.00
68,124.00
growth rate 0.9% 6.3% -0.9% -2.9%
Cash 3,301.00
1,830.00
1,749.00
1,818.00
785.00
growth rate -44.6% -4.4% 4.0% -56.8%
Inventory 8,899.00
10,010.00
10,316.00
9,889.00
9,565.00
growth rate 12.5% 3.1% -4.1% -3.3%
Cur.Liabilities 18,547.00
20,517.00
22,559.00
21,482.00
21,667.00
growth rate 10.6% 10.0% -4.8% 0.9%
Liabilities 37,735.00
39,862.00
42,638.00
41,682.00
41,435.00
growth rate 5.6% 7.0% -2.2% -0.6%
LT Debt 12,684.00
12,738.00
12,532.00
12,456.00
12,431.00
growth rate 0.4% -1.6% -0.6% -0.2%
Equity 27,466.00
25,929.00
27,355.00
27,736.00
26,007.00
growth rate -5.6% 5.5% 1.4% -6.2%
Common Shares 12.00
12.00
12.00
12.00
12.00
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Aug '17 Nov '17 Feb '18 May '18 Aug '18
Capital Expenditures 439.00
378.00
288.00
317.00
384.00
growth rate -13.9% -23.8% 10.1% 21.1%
Cash Dividends 409.00
413.00
402.00
476.00
448.00
growth rate 1.0% -2.7% 18.4% -5.9%
Cash From OA 2,014.00
961.00
2,215.00
2,209.00
2,880.00
growth rate -52.3% 130.5% -0.3% 30.4%
Sale Purchase of Stock 43.00
32.00
51.00
35.00
growth rate -25.6% 59.4% -31.4%
FCF 1,575.00
583.00
1,927.00
1,892.00
2,496.00
growth rate -63.0% 230.5% -1.8% 31.9%
Income Statement Aug '17 Nov '17 Feb '18 May '18 Aug '18
Sales 30,149.00
30,740.00
33,021.00
34,334.00
33,442.00
growth rate 2.0% 7.4% 4.0% -2.6%
Op.Income 1,991.00
1,453.00
1,942.00
1,465.00
1,503.00
growth rate -27.0% 33.7% -24.6% 2.6%
IBT 933.00
1,049.00
1,852.00
1,455.00
1,673.00
growth rate 12.4% 76.6% -21.4% 15.0%
Net Income 802.00
821.00
1,349.00
1,342.00
1,512.00
growth rate 2.4% 64.3% -0.5% 12.7%
Gross Profit 7,340.00
7,341.00
8,096.00
7,780.00
7,575.00
growth rate 0.0% 10.3% -3.9% -2.6%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (69.06)

YOY Growth Grade:

D (37.66)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 15.36 15.26 11.01
EPS / Growth 14.1% 5.05 11.8%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 0.1%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 0.1% 8.7% 8.7%
Future PE 0.20 14.58 14.58
Future EPS 5.10 11.61 11.61
Value Price
MOS %
0.25
-99.7%
41.82
-45.7%
41.82
-45.7%
MOS Price 0.13 20.91 20.91
IRT 15.14 9.56 9.56

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.